Vitamin D3 and B12 supplementation in pregnancy.


Journal

Diabetes research and clinical practice
ISSN: 1872-8227
Titre abrégé: Diabetes Res Clin Pract
Pays: Ireland
ID NLM: 8508335

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 29 12 2020
revised: 08 02 2021
accepted: 12 02 2021
pubmed: 5 3 2021
medline: 29 5 2021
entrez: 4 3 2021
Statut: ppublish

Résumé

To assess the efficacy of vitamin D3 or B12 supplementation during pregnancy. Pregnant women at 6-14 weeks in the intervention arm received oral high dose intermittent vitamin D3 and/or low dose B12 supplementation if they had vitamin D or vitamin B12 deficiency. The control arm received prescribed dietary instruction only. An additional observational arm for those mothers at booking with normal vitamin D and vitamin B12 level was also recruited. All groups received standard care during pregnancy. The primary endpoint of either vitamin D or B12 at term was not met. At baseline 25% participants in both the interventional and control arms had severe D deficiency (<30 nmol/l), reducing to under 3.4% in both groups. No maternal differences in vitamin D or B12 levels were found at delivery between the intervention, control, or observational groups. No significant difference in any of the pregnancy or birth outcomes was observed between three groups. In this study, oral supplementation of high dose intermittent vitamin D or low dose vitamin B12 regime failed to correct the relevant nutritional deficiencies in Bangladeshi pregnant women as per protocol. Both dietary supplementation and high dose vitamin D corrected severe vitamin deficiency.

Identifiants

pubmed: 33662489
pii: S0168-8227(21)00081-4
doi: 10.1016/j.diabres.2021.108728
pii:
doi:

Substances chimiques

Cholecalciferol 1C6V77QF41
Vitamin B 12 P6YC3EG204

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

108728

Informations de copyright

Copyright © 2021. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Bishwajit Bhowmik (B)

Centre of Global Health Research, Diabetic Association of Bangladesh, Dhaka 1200, Bangladesh.

Tasnima Siddiquee (T)

Centre of Global Health Research, Diabetic Association of Bangladesh, Dhaka 1200, Bangladesh.

Ibrahimu Mdala (I)

Institute of Health and Society, Faculty of Medicine, University of Oslo, 0318 Oslo, Norway.

Liya Quamrun Nesa (L)

Centre of Global Health Research, Diabetic Association of Bangladesh, Dhaka 1200, Bangladesh.

Samsad Jahan Shelly (S)

Department of Obstetrics and Gynecology, Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders, Dhaka 1200, Bangladesh.

Zahid Hassan (Z)

Department of Biochemistry & Cell Biology, Bangladesh University of Health Sciences, Dhaka 1216, Bangladesh.

Nayla Cristina do V Moreira (NCDV)

Faculty of Medicine, Federal University of Ceara (FAMED-UFC), Fortaleza-Ceara 60020-181, Brazil; Institute of Health and Society, Faculty of Medicine, University of Oslo, 0318 Oslo, Norway.

Ishrat Jahan (I)

Maternal and Child Health Training Institute, Azimpur, Dhaka 1205, Bangladesh.

A K Azad Khan (AK)

Centre of Global Health Research, Diabetic Association of Bangladesh, Dhaka 1200, Bangladesh.

Graham A Hitman (GA)

Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, 4 Newark Street, London E1 2AT, United Kingdom.

Akhtar Hussain (A)

Centre of Global Health Research, Diabetic Association of Bangladesh, Dhaka 1200, Bangladesh; Faculty of Medicine, Federal University of Ceara (FAMED-UFC), Fortaleza-Ceara 60020-181, Brazil; Faculty of Health Sciences, Nord University, Bodø 8049, Norway; International Diabetes Federation (IDF), 166 Chaussee de La Hulpe, B - 1170 Brussels, Belgium. Electronic address: hussain.akhtar@nord.no.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH